Clinical Trials Directory

Trials / Unknown

UnknownNCT05778110

Multiomic Analysis of Traumatic Brain Injury and Hypertension Intracranial Hemorrhage Lesion Tissue

Status
Unknown
Phase
Study type
Observational
Enrollment
10 (estimated)
Sponsor
RenJi Hospital · Academic / Other
Sex
All
Age
16 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The goal of this experimental observation study is to figure out differently expressed biomarkers in lesion tissues in traumatic brain injury or hypertension intracranial hemorrhage patients. The main questions it aims to answer is: * Which RNA, protein and metabolites are differently expressed in lesion tissues? * What molecular mechanism is participated in TBI or ICH? Participants will be treated by emergency operation, and their lesion tissues will be collected during the operation.

Conditions

Interventions

TypeNameDescription
OTHERType of diseaseDifferent types of pathogen: brain injury by trauma or intracranial hemorrhage due to hypertension.

Timeline

Start date
2023-04-01
Primary completion
2024-03-31
Completion
2024-12-31
First posted
2023-03-21
Last updated
2023-05-03

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05778110. Inclusion in this directory is not an endorsement.

Multiomic Analysis of Traumatic Brain Injury and Hypertension Intracranial Hemorrhage Lesion Tissue (NCT05778110) · Clinical Trials Directory